KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Eli Lilly (LLY) Income from Continuing Operations (2016 - 2025)

Eli Lilly's Income from Continuing Operations history spans 17 years, with the latest figure at 6637700000.0 for Q4 2025.

  • For Q4 2025, Income from Continuing Operations rose 50.52% year-over-year to 6637700000.0; the TTM value through Dec 2025 reached 20640000000.0, up 94.9%, while the annual FY2025 figure was 20640000000.0, 94.9% up from the prior year.
  • Income from Continuing Operations reached 6637700000.0 in Q4 2025 per LLY's latest filing, up from 5582500000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 6637700000.0 in Q4 2025 to a low of 57400000.0 in Q3 2023.
  • Average Income from Continuing Operations over 5 years is 2414825000.0, with a median of 1833050000.0 recorded in 2022.
  • Peak YoY movement for Income from Continuing Operations: tumbled 103.95% in 2023, then soared 1790.42% in 2024.
  • A 5-year view of Income from Continuing Operations shows it stood at 1726100000.0 in 2021, then rose by 12.26% to 1937700000.0 in 2022, then increased by 12.98% to 2189300000.0 in 2023, then skyrocketed by 101.43% to 4409800000.0 in 2024, then soared by 50.52% to 6637700000.0 in 2025.
  • Per Business Quant, the three most recent readings for LLY's Income from Continuing Operations are 6637700000.0 (Q4 2025), 5582500000.0 (Q3 2025), and 5660500000.0 (Q2 2025).